Bone mineral density in pseudohypoparathyroidism type 1a

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 9, 2010, Pages 4465-4475

  Long, Dominique N ^a   Levine, Michael A ^b   Germain Lee, Emily L ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c KENNEDY KRIEGER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; GROWTH HORMONE; PARATHYROID HORMONE; PHOSPHATE; THYROTROPIN; THYROID HORMONE;

ADOLESCENT; ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; BONE AGE; BONE DENSITY; BONE MINERAL; CALCIUM BLOOD LEVEL; CHILD; CLINICAL ARTICLE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; GROWTH HORMONE BLOOD LEVEL; HUMAN; LUMBAR SPINE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PSEUDOHYPOPARATHYROIDISM; PUBERTY; RISK ASSESSMENT; THYROTROPIN BLOOD LEVEL; BLOOD; CASE CONTROL STUDY; CLASSIFICATION; CLINICAL TRIAL; MALE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHOTON ABSORPTIOMETRY; PRESCHOOL CHILD; YOUNG ADULT;

ABSORPTIOMETRY, PHOTON; ADOLESCENT; ADULT; BONE DENSITY; CALCIUM; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MIDDLE AGED; PARATHYROID HORMONE; PSEUDOHYPOPARATHYROIDISM; THYROID HORMONES; YOUNG ADULT;

EID: 77956579375     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0498     Document Type: Article

References (61)

1. Levine MA, Germain-Lee E, Jan de Beur SM 2003 Genetic basis for resistance to parathyroid hormone. Horm Res 60(Suppl 3):87-95
2. Plagge A, Kelsey G, Germain-Lee EL 2008 Physiological functions of the imprinted Gnas locus and its protein variants Gαs and XLαs in human and mouse. J Endocrinol 196:193-214
3. Germain-Lee EL, Ding CL, Deng Z, Crane JL, Saji M, Ringel MD, Levine MA 2002 Paternal imprinting of Gαs in the human thyroid as the basis of TSH resistance in pseudohypoparathyroidism type 1a. Biochem Biophys Res Commun 296:67-72
4. Mantovani G, Ballare E, Giammona E, Beck-Peccoz P, Spada A 2002 The Gαs gene: predominant maternal origin of transcription in human thyroid gland and gonads. J Clin Endocrinol Metab 87:4736-4740
5. Liu J, Erlichman B, Weinstein LS 2003 The stimulatory G protein α-subunit Gsα is imprinted in human thyroid glands: implications for thyroid function in pseudohypoparathyroidism types1A and 1B. J Clin Endocrinol Metab 88:4336-4341
6. Hayward BE, Barlier A, Korbonits M, Grossman AB, Jacquet P, Enjalbert A, Bonthron DT 2001 Imprinting of the G(s)α gene GNAS1 in the pathogenesis of acromegaly. J Clin Invest 107:R31-R36
7. Germain-Lee EL, Schwindinger W, Crane JL, Zewdu R, Zweifel LS, Wand G, Huso DL, Saji M, Ringel MD, Levine MA 2005 A mouse model of Albright hereditary osteodystrophy generated by targeted disruption of exon 1 of the Gnas gene. Endocrinology 146:4697-4709
8. Shore EM, Ahn J, Jan de Beur S, Li M, Xu M, Gardner RJ, Zasloff MA, Whyte MP, Levine MA, Kaplan FS 2002 Paternally inherited inactivating mutations of the GNAS1 gene in progressive osseous heteroplasia. N Engl J Med 346:99-106
9. de Nanclares GP, Fernández-Rebollo E, Santin I, Garcia-Cuartero B, Gaztambide S, Menéndez E, Morales MJ, Pombo M, Bilbao JR, Barros F, Zazo N, Ahrens W, Jüppner H, Hiort O, Castaño L, Bastepe M 2007 Epigenetic defects of GNAS in patients with pseudohypoparathyroidism and mild features of Albright's hereditary osteodystrophy. J Clin Endocrinol Metab 92:2370-2373
10. Levine MA, Zapalowski C, Kappy MS 2005 Disorders of calcium, phosphate, parathyroid hormone and vitamin D. In: Kappy MS, Allen DB, Geffner ME, eds. Principles and practice of pediatric endocrinology. Springfield, IL: Charles C. Thomas; 695-814
11. Linglart A, Gensure RC, Olney RC, Jüppner H, Bastepe M 2005 A novel STX16 deletion in autosomal dominant pseudohypoparathyroidism type Ib redefines the boundaries of a cis-acting imprinting control element of GNAS. Am J Hum Genet 76:804-814
12. Bastepe M, Fröhlich LF, Hendy GN, Indridason OS, Josse RG, Koshiyama H, Körkkö J, Nakamoto JM, Rosenbloom AL, Slyper AH, Sugimoto T, Tsatsoulis A, Crawford JD, Jüppner H 2003 Autosomal dominant pseudohypoparathyroidism type Ib is associated with a heterozygous microdeletion that likely disrupts a putative imprinting control element of GNAS. J Clin Invest 112:1255-1263
13. Bastepe M, Fröhlich LF, Linglart A, Abu-Zahra HS, Tojo K, Ward LM, Jüppner H 2005 Deletion of the NESP55 differentially methylated region causes loss of maternal GNAS imprints and pseudohypoparathyroidism type Ib. Nat Genet 37:25-27
14. Jüppner H, Linglart A, Fröhlich LF, Bastepe M 2006 Autosomal-dominant pseudohypoparathyroidism type Ib is caused by different microdeletions within or upstream of the GNAS locus. Ann NY Acad Sci 1068:250-255 (Pubitemid 43824157)
15. Ferrandon S, Feinstein TN, Castro M, Wang B, Bouley R, Potts JT, Gardella TJ, Vilardaga JP 2009 Sustained cyclic AMP production by parathyroid hormone receptor endocytosis. Nat Chem Biol 5:734-742
16. Germain-Lee EL, Groman J, Crane JL, Jan de Beur SM, Levine MA 2003 Growth hormone deficiency in pseudohypoparathyroidism type 1a: Another manifestation of multi-hormone resistance. J Clin Endocrinol Metab 88:4059-4069
17. Bastepe M, Weinstein LS, Ogata N, Kawaguchi H, Jüppner H, Kronenberg HM, Chung UI 2004 Stimulatory G protein directly regulates hypertrophic differentiation of growth plate cartilage in vivo. Proc Natl Acad Sci USA 101:14794-14799
18. Sakamoto A, Chen M, Kobayashi T, Kronenberg HM, Weinstein LS 2005 Chondrocyte-specific knockout of the G protein G(s)α leads to epiphyseal and growth plate abnormalities and ectopic chondrocyte formation. J Bone Miner Res 20:663-671
19. Karaplis AC, Luz A, Glowacki J, Bronson RT, Tybulewicz VL, Kronenberg HM, Mulligan RC 1994 Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev 8:277-289
20. Klopocki E, Hennig BP, Dathe K, Koll R, de Ravel T, Baten E, Blom E, Gillerot Y, Weigel JF, Kruger G, Hiort O, Seemann P, Mundlos S 2010 Deletion and point mutations of PTHLH cause brachydactyly type E. Am J Hum Genet 86:434-439
21. Jobert AS, Zhang P, Couvineau A, Bonaventure J, Roume J, Le Merrer M, Silve C 1998 Absence of functional receptors for parathyroid hormone and parathyroid hormone-related peptide in Blomstrand chondrodysplasia. J Clin Invest 102:34-40
22. Mantovani G, Bondioni S, Locatelli M, Pedroni C, Lania AG, Ferrante E, Filopanti M, Beck-Peccoz P, Spada A 2004 Biallelic expression of the Gsα gene in human bone and adipose tissue. J Clin Endocrinol Metab 89:6316-6319
23. Kidd GS, Schaaf M, Adler RA, Lassman MN, Wray HL 1980 Skeletal responsiveness in pseudohypoparathyroidism: a spectrum of clinical disease. Am J Med 68:772-781
24. Murray TM, Rao LG, Wong MM, Waddell JP, McBroom R, Tam CS, Rosen F, Levine MA 1993 Pseudohypoparathyroidism with osteitis fibrosa cystica: direct demonstration of skeletal responsiveness to parathyroid hormone in cells cultured from bone. J Bone Miner Res 8:83-91
25. Eubanks PJ, Stabile BE 1998 Osteitis fibrosa cystica with renal parathyroid hormone resistance: a review of pseudohypoparathyroidism with insight into calcium homeostasis. Arch Surg 133:673-676
26. Cohen RD, Vince FP 1969 Pseudohypoparathyroidism with raised plasma alkaline phosphatase. Arch Dis Child 44:96-101
27. Kolb FO, Steinbach HL 1962 Pseudohypoparathyroidism with secondary hyperparathyroidism and osteitis fibrosa. J Clin Endocrinol Metab 22:59-70
28. Giraud P, Audran M, Rohmer V, Jallet P, Basle MF, Bregeon C, Bigorgne JC 1995 Direct effect of calcitriol on the regulation of parathyroid hormone secretion in a case of pseudo-hypoparathyroidism (a 24-month follow-up study). Clin Rheumatol 14:287-291
29. Tollin SR, Perlmutter S, Aloia JF 2000 Serial changes in bone mineral density and bone turnover after correction of secondary hyperparathyroidism in a patient with pseudohypoparathyroidism type Ib. J Bone Miner Res 15:1412-1416
30. Ish-Shalom S, Rao LG, Levine MA, Fraser D, Kooh SW, Josse RG, McBroom, Wong MM, Murray TM 1996 Normal parathyroid hormone responsiveness of bone-derived cells from a patient with pseudohypoparathyroidism. J Bone Miner Res 11:8-14
31. Breslau NA, Moses AM, Pak CYC 1983 Evidence for bone remodeling but lack of calcium mobilization response to parathyroid hormone in pseudohypoparathyroidism. J Clin Endocrinol Metab 57:638-644
32. Kanatani M, Sugimoto T, Kaji H, Ikeda K, Chihara K 2001 Skeletal responsiveness to parathyroid hormone in pseudohypoparathyroidism. Eur J Endocrinol 144:263-269
33. Touliatos JS, Sebes JI, Hinton A, McCommon D, Karas JG, Palmieri GM 1995 Hypoparathyroidism counteracts risk factors for osteoporosis. Am J Med Sci 310:56-60
34. Ahmed SF, Russell S, Rashid R, Beattie TJ, Murphy AV, Ramage IJ, Maxwell H 2005 Bone mineral content, corrected for height or bone area, measured by DXA is not reduced in children with chronic renal disease or in hypoparathyroidism. Pediatr Nephrol 20:1466-1472
35. Germain-Lee EL 2006 Short stature, obesity, and growth hormone deficiency in pseudohypoparathyroidism type 1a. Pediatr Endocrinol Rev 3(Suppl 2):318-327
36. Ellis KJ, Shypailo RJ 1998 Bone mineral and body composition measurements: cross-calibration of pencil-beam and fan-beam dual-energy X-ray absorptiometers. J Bone Miner Res 13:1613-1618
37. Zemel BS, Leonard MB, Kelly A, Lappe JM, Gilsanz V, Oberfield S, Mahboubi S, Shepherd JA, Hangartner TN, Frederick MM, Winer KK, Kalkwarf HJ 2010 Height adjustment in assessing dual energy X-ray absorptiometry measurements of bone mass and density in children. J Clin Endocrinol Metab 95:1265-1273
38. Long DN, McGuire S, Levine MA, Weinstein LS, Germain-Lee EL 2007 Body mass index differences in pseudohypoparathyroidism type 1a versus pseudopseudohypoparathyroidism may implicate paternal imprinting of Gαs in the development of human obesity. J Clin Endocrinol Metab 92:1073-1079
39. Bachrach LK 2005 Osteoporosis and measurement of bone mass in children and adolescents. Endocrinol Metab Clin North Am 34:521-535, vii
40. Rubin MR, Cosman F, Lindsay R, Bilezikian JP 2002 The anabolic effects of parathyroid hormone. Osteoporos Int 13:267-277
41. Thomas T 2006 Intermittent parathyroid hormone therapy to increase bone formation. Joint Bone Spine 73:262-269
42. Laway BA, Goswami R, Singh N, Gupta N, Seith A 2006 Pattern of bone mineral density in patients with sporadic idiopathic hypoparathyroidism. Clin Endocrinol (Oxf) 64:405-409
43. Chan FK, Tiu SC, Choi KL, Choi CH, Kong AP, Shek CC 2003 Increased bone mineral density in patients with chronic hypoparathyroidism. J Clin Endocrinol Metab 88:3155-3159
44. Rubin MR, Dempster DW, Zhou H, Shane E, Nickolas T, Sliney J, Silverberg SJ, Bilezikian JP 2008 Dynamic and structural properties of the skeleton in hypoparathyroidism. J Bone Miner Res 23:2018-2024
45. Heaney RP 2003 Bone mineral content, not bone mineral density, is the correct bone measure for growth studies. Am J Clin Nutr 78:350-351; author reply 351-352
46. Nevill AM, Holder RL, Maffulli N, Cheng JC, Leung SS, Lee WT, Lau JT 2002 Adjusting bone mass for differences in projected bone area and other confounding variables: an allometric perspective. J Bone Miner Res 17:703-708
47. Gordon CM, Bachrach LK, Carpenter TO, Crabtree N, El-Hajj Fuleihan G, Kutilek S, Lorenc RS, Tosi LL, Ward KA, Ward LM, Kalkwarf HJ 2008 Dual energy X-ray absorptiometry interpretation and reporting in children and adolescents: the 2007 ISCD Pediatric Official Positions. J Clin Densitom 11:43-58
48. Ueno Y, Shinki T, Nagai Y, Murayama H, Fujii K, Suda T 2003 In vivo administration of 1,25-dihydroxyvitamin D3 suppresses the expression of RANKL mRNA in bone of thyroparathyroidectomized rats constantly infused with PTH. J Cell Biochem 90:267-277
49. Miao D, He B, Lanske B, Bai XY, Tong XK, Hendy GN, Goltzman D, Karaplis AC 2004 Skeletal abnormalities in Pth-null mice are influenced by dietary calcium. Endocrinology 145:2046-2053
50. Langdahl BL, Mortensen L, Vesterby A, Eriksen EF, Charles P 1996 Bone histomorphometry in hypoparathyroid patients treated with vitamin D. Bone 18:103-108
51. Rubin MR, Dempster DW, Kohler T, Stauber M, Zhou H, Shane E, Nickolas T, Stein E, Sliney Jr J, Silverberg SJ, Bilezikian JP, Müller R 2010 Three dimensional cancellous bone structure in hypoparathyroidism. Bone 46:190-195
52. Cohen A, Dempster DW, Müller R, Guo XE, Nickolas TL, Liu XS, Zhang XH, Wirth AJ, van Lenthe GH, Kohler T, McMahon DJ, Zhou H, Rubin MR, Bilezikian JP, Lappe JM, Recker RR, Shane E 2010 Assessment of trabecular and cortical architecture and mechanical competence of bone by high-resolution peripheral computed tomography: comparison with transiliac bone biopsy. Osteoporos Int 21:263-273
53. Rubin MR, Sliney Jr J, McMahon DJ, Silverberg SJ, Bilezikian JP 22 January 2010 Therapy of hypoparathyroidism with intact parathyroid hormone. Osteoporos Int 10.1007/s00198-009-1149x
54. Greenspan SL, Bone HG, Ettinger MP, Hanley DA, Lindsay R, Zanchetta JR, Blosch CM, Mathisen AL, Morris SA, Marriott TB 2007 Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial. Ann Intern Med 146:326-339
55. Hodsman AB, Hanley DA, Ettinger MP, Bolognese MA, Fox J, Metcalfe AJ, Lindsay R 2003 Efficacy and safety of human parathyroid hormone-(1-84) in increasing bone mineral density in postmenopausal osteoporosis. J Clin Endocrinol Metab 88:5212-5220
56. Yeo GS, Lank EJ, Farooqi IS, Keogh J, Challis BG, O'Rahilly S 2003 Mutations in the human melanocortin-4 receptor gene associated with severe familial obesity disrupts receptor function through multiple molecular mechanisms. Hum Mol Genet 12:561-574
57. Ahn JD, Dubern B, Lubrano-Berthelier C, Clement K, Karsenty G 2006 Cart overexpression is the only identifiable cause of high bone mass in melanocortin 4 receptor deficiency. Endocrinology 147:3196-3202
58. Chen M, Wang J, Dickerson KE, Kelleher J, Xie T, Gupta D, Lai EW, Pacak K, Gavrilova O, Weinstein LS 2009 Central nervous system imprinting of the G protein G(s)α and its role in metabolic regulation. Cell Metab 9:548-555
59. Siris ES, Miller PD, Barrett-Connor E, Faulkner KG, Wehren LE, Abbott TA, Berger ML, Santora AC, Sherwood LM 2001 Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA 286:2815-2822
60. Clark EM, Tobias JH, Ness AR 2006 Association between bone density and fractures in children: a systematic review and meta-analysis. Pediatrics 117:e291-e297
61. Clark EM, Ness AR, Bishop NJ, Tobias JH 2006 Association between bone mass and fractures in children: a prospective cohort study. J Bone Miner Res 21:1489-1495